Indian markets ended the previous session with modest gains. On November 3, 2025, the BSE Sensex rose 39.78 points (0.05%) to close at 83,978.49, while the NSE Nifty 50 gained 41.25 points (0.16%) to finish at 25,763.35.
Investor focus on November 4 will be on the telecom, pharma, and financial sectors, as key companies announce strategic investments, capital plans, and earnings updates.
Cipla announced the acquisition of a 100% stake in Inzpera Healthsciences Ltd for approximately ₹110.65 crore, valuing the transaction at an enterprise value of ₹120 crore. The deal, which will make Inzpera a wholly owned subsidiary, is expected to be completed within a month, subject to customary closing conditions.
Bharti Airtel reported a 14.2% sequential rise in consolidated net profit to ₹6,791 crore for Q2 FY26. Revenue increased 5.4% QoQ to ₹52,145 crore, and EBITDA grew 6.2% to ₹29,561 crore, supported by robust performance across its mobile and enterprise divisions.
Gland Pharma posted a 12.3% year-on-year growth in net profit to ₹184 crore for Q2 FY26, driven by sustained momentum in its injectables segment. Revenue advanced 5.8% YoY to ₹1,486.8 crore, while EBITDA stood at ₹314 crore with stable margins of 21.1%.
Godfrey Phillips delivered a strong performance in Q2 FY26, with net profit rising 22.9% YoY to ₹305 crore, aided by improved margins despite flat revenue at ₹1,632 crore. EBITDA climbed 13.4% to ₹314.5 crore, expanding margins to 19.3% from 17%. The company declared an 850% interim dividend (₹17 per share).
Shareholders holding the company’s shares in their demat accounts as of the record date will be eligible to receive the dividend payout.
Bharti Hexacom, a subsidiary of Bharti Airtel, reported a 66.4% YoY surge in net profit to ₹421 crore for Q2 FY26, fueled by higher ARPU and growing mobile data consumption. Revenue rose 10.5% YoY to ₹2,317 crore, while ARPU increased to ₹251 from ₹228 last year, driven by rising smartphone adoption and a 27% jump in average monthly data usage.
Read More: Key Trends to Watch in November 2025: Auto Sales, Key IPOs, Inflation Data, and Trade Developments.
As markets open the new session, traders and investors are expected to track earnings momentum in telecom and pharma, dividend payouts, and capital raising decisions from key firms. Focus will remain on corporate actions that could influence near term market direction.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Nov 4, 2025, 8:39 AM IST
Neha Dubey
Neha Dubey is a Content Analyst with 3 years of experience in financial journalism, having written for a leading newswire agency and multiple newspapers. At Angel One, she creates daily content on finance and the economy. Neha holds a degree in Economics and a Master’s in Journalism.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
EN